Restless legs syndrome in hemodialysis patients Restless legs syndrome, hemodialysis, end stage kidney disease, intradialytic exercise, gabapentin
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 20 years old or older, 2. End stage renal disease patients undergoing hemodialysis at least 3 months with adequate dialysis delivery, 3. Diagnosis of Restless legs syndrome based on international RLS study Group, 4. Persistent Restless legs syndrome symptoms occurring at least twice per week , 5. Informed consent
Exclusion criteria
Exclusion criteria: 1. Use of gabapentin or dopamine agonists for restless legs syndrome treatment within the past 12 weeks 2.Ferritin level < 200 ng/ml, 3.Pregnancy , 4.Diagnostic of depression or psychiatric disorder, 5.Obstructive sleep apnea , 6.Physical limitations such as leg amputation, 7.Unstable patients or critical illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in international Restless legs syndrome study group severity scale and grading between groups 12 weeks international Restless legs syndrome study group rating scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life and sleep quality 12 weeks Kidney disease specific quality of life 36 questionnaires (KDQOL-36), Epworth sleepiness score questionnaires | — |
Countries
Thailand
Contacts
Phramongkutklao Hospital